Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

PheWeb

No definition available.

Endpoint definition

↥

FinnGen phenotype data

Filter registries Inpat., Oupat., Death

Hospital Discharge: ICD-10 B21

Cause of death: ICD-10 B21

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

AB1_HIV_MALIGNANT

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF5

Similar endpoints

↥

List of similar endpoints to Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	18	-	14
Unadjusted prevalence (%)	0.01	-	0.01
Mean age at first event (years)	42.83	-	42.58

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Correlations

↥

Index endpoint: AB1_HIV_MALIGNANT – Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms
GWS hits:

Survival analyses between endpoints

↥

Plot

before Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms
after Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

↥